Metfienz-PG1 Tablet SR
Marketer
Plena Remedies
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Metfienz-PG1 Tablet SR
Glycemia-Control SR is a dual-action tablet formulated to manage blood glucose. This medication, used alongside a healthy diet and regular exercise, enhances glycemic control in adult patients with type 2 diabetes. It promotes efficient insulin utilization, consequently reducing blood sugar. Glycemia-Control SR should be administered precisely as prescribed by your physician, including dosage and frequency. Ingestion with food is recommended to minimize gastrointestinal discomfort. If a dose is missed, take it immediately; however, if the next dose is imminent, omit the missed dose and resume your usual schedule. Never double the dose. Overdosage can result in hypoglycemia (low blood sugar). Concomitant use with other antidiabetic medications, alcohol consumption, or skipped meals may increase the risk of hypoglycemia. Regular blood glucose monitoring is crucial during treatment. Common adverse effects may include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any pre-existing kidney, liver, or heart conditions to your doctor. Pregnant or lactating women should seek medical counsel before use. Kidney function tests will be assessed before treatment initiation. Limit alcohol consumption as it may heighten the likelihood of side effects.
Uses of Metfienz-PG1 Tablet SR
Managing Type 2 Diabetes
Major Benefits of Metfienz-PG1 Tablet SR:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Metfienz-PG1 Tablet SR should be administered with a meal.
Common Side effects of Metfienz-PG1 Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Metfienz-PG1 Tablet SR:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Metfienz-PG1 Tablet SR should be administered with a meal.
How Metfienz-PG1 Tablet SR works:
Metfienz-PG1 SR tablets contain a triple-action antidiabetic formulation: glimepiride, metformin, and pioglitazone. These medications employ distinct mechanisms to optimize blood sugar management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release, thereby reducing blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness. Pioglitazone, a thiazolidinedione, further improves insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol consumption and Metfienz-PG1 Tablet SR is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Using Metfienz-PG1 Tablet SR during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the potential benefits against these risks prior to prescribing. Consult your doctor for advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Metfienz-PG1 tablets are likely unsafe for breastfeeding mothers. Available human data indicates potential transfer of the medication into breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if such symptoms arise.
KidneyCAUTION
Patients with kidney impairment should use Metfienz-PG1 Tablet SR cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates its use. Consult your physician. Kidney function should be regularly monitored during treatment with this medication.
LiverCAUTION
Patients with liver impairment should exercise caution when using Metfienz-PG1 Tablet SR; dosage modification may be necessary. Consult a physician for guidance. Metfienz-PG1 Tablet SR is contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Metfienz-PG1 Tablet SR :
Should you forget a Metfienz-PG1 Tablet SR dose, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication timetable. Avoid taking a double dose.
Facts to Know About Metfienz-PG1 Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently